Crystalline bromodomain inhibitors

Crystalline bromodomain inhibitors

  • CN 105,473,586 A
  • Filed: 06/27/2014
  • Published: 04/06/2016
  • Est. Priority Date: 06/28/2013
  • Status: Active Application
First Claim
Patent Images

1. N-[4-(2,4-difluoro phenoxy group)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo-[2,3-c] pyridin-4-yl) phenyl] crystallized form of separation of ethyl sulfonamide, wherein, described crystallized form has and comprises the three or more x-ray diffractogram of powder being selected from 2 following θ

  • peak value ±

    0.2;

    6.2 °

    , 9.0 °

    , 12.3 °

    , 12.6 °

    , 15.6 °

    , 22.1 °

    , 25.6 °

    , 26.3 °

    , 27.0 ° and

    27.3 °

    .

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×